Patents by Inventor Azucena Castro Espido

Azucena Castro Espido has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11899027
    Abstract: The present invention relates to methods for the diagnosis of NAFLD in a subject, and for the differential diagnosis of NASH or steatosis in a subject suffering from NAFLD, based on the determination in a sample of metabolic markers, particularly lipid metabolic markers.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: February 13, 2024
    Assignee: RUBIO METABOLOMICS, S.L.U.
    Inventors: Ibon Martinez Arranz, Rebeca Mayo Sanchez, Azucena Castro Espido, Jose Maria Mato De La Paz
  • Publication number: 20190219602
    Abstract: The present invention relates to methods for the diagnosis of NAFLD in a subject, and for the differential diagnosis of NASH or steatosis in a subject suffering from NAFLD, based on the determination in a sample of metabolic markers, particularly lipid metabolic markers.
    Type: Application
    Filed: July 6, 2017
    Publication date: July 18, 2019
    Inventors: Ibon Martinez Arranz, Rebeca Mayo Sanchez, Azucena Castro Espido, Jose Maria Mato De La Paz
  • Patent number: 8758992
    Abstract: The invention relates to methods for the diagnosis of non-alcoholic steatosis (NASH). The method relies on the determination of certain metabolic markers in a biological sample of the patient which are up- or down-regulated in the NASH patients vs. patients with a simple fatty liver (steatosis).
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: June 24, 2014
    Assignee: One Way Liver Genomics, S.L.
    Inventors: Jonathan Barr, Azucena Castro Espido, Jose Maria Mato De La Paz, Maria Luz Martinez Chantar
  • Patent number: 8563318
    Abstract: The invention relates to methods for the diagnosis of non-alcoholic steatosis (NASH). The method relies on the determination of certain metabolic markers in a biological sample of the patient which are up- or down-regulated in the NASH patients vs. patients with a simple fatty liver (steatosis).
    Type: Grant
    Filed: August 11, 2009
    Date of Patent: October 22, 2013
    Assignee: One Way Liver Genomics, S.L.
    Inventors: Jonathan Barr, Azucena Castro Espido, Jose Maria Mato De La Paz, Maria Luz Martinez Chantar
  • Publication number: 20120187289
    Abstract: The invention relates to methods for the diagnosis of non-alcoholic steatosis (NASH). The method relies on the determination of certain metabolic markers in a biological sample of the patient which are up- or down-regulated in the NASH patients vs. patients with a simple fatty liver (steatosis).
    Type: Application
    Filed: September 20, 2010
    Publication date: July 26, 2012
    Applicant: One Way Liver Genomics, S.L.
    Inventors: Jonathan Barr, Azucena Castro Espido, Jose Maria Mato De La Paz, Maria Luz Martinez Chantar
  • Publication number: 20110180703
    Abstract: The invention relates to methods for the diagnosis of non-alcoholic steatosis (NASH). The method relies on the determination of certain metabolic markers in a biological sample of the patient which are up- or down-regulated in the NASH patients vs. patients with a simple fatty liver (steatosis).
    Type: Application
    Filed: August 11, 2009
    Publication date: July 28, 2011
    Applicant: ONE WAY LIVER GENOMICS, S.L.
    Inventors: Jonathan Barr, Azucena Castro Espido, Jose Maria Mato De La Paz, Maria Luz Martinez Chantar